About diaDexus (OTCMKTS:DDXS)
Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of their patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.
Industry, Sector and Symbol
Trailing P/E Ratio-0.00452261306532663
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on Assets-58.13%
diaDexus (OTCMKTS:DDXS) Frequently Asked Questions
What is diaDexus' stock symbol?
diaDexus trades on the OTCMKTS under the ticker symbol "DDXS."
How were diaDexus' earnings last quarter?
diaDexus, Inc. (OTCMKTS:DDXS) issued its earnings results on Monday, October, 26th. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.69) by $0.35. View diaDexus' Earnings History.
Who are some of diaDexus' key competitors?
Some companies that are related to diaDexus include Cache (CACH), Gordmans Stores (GMANQ), NephroGenex (NRXGQ), School Specialty (SCHSQ), Local (LOCMQ), Circle Star Energy (CRCL), Body Central (BODY), Alco Stores (ALCSQ), Shale Oil International (SHLE), New Western Energy (NWTR), ITT Educational Services (ESINQ), CTPartners Executive Search (CTPR), Alexza Pharmaceuticals (ALXA), Altice S A (ATCEY), AMS (AMSSY), ATP Oil & Gas (ATPAQ), BG Group (BRGYY) and BPZ Resources (BPZRQ).
Who are diaDexus' key executives?
diaDexus' management team includes the folowing people:
- Lori F. Rafield Ph.D., Chairman of the Board, Chief Executive Officer (Age 60)
- Leone D. Patterson, Chief Financial Officer (Age 54)
- Emi Zychlinsky Ph.D., Executive Vice President, Chief Technology Officer (Age 59)
- Christopher P. Lowe, Chief Accounting Officer (Age 46)
- Jonathan Ruais, Vice President of Marketing
- Kenneth C. Fang M.D., Chief Medical Officer (Age 53)
- R. Michael Richey, Chief Business Officer (Age 60)
- James R. Sulat, Director (Age 66)
- John T. Curnutte M.D. Ph.D., Independent Director (Age 65)
- Karen Drexler, Independent Director (Age 55)
How do I buy diaDexus stock?
Shares of diaDexus can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is diaDexus' stock price today?
One share of diaDexus stock can currently be purchased for approximately $0.01.
How big of a company is diaDexus?
diaDexus has a market capitalization of $36,900.00.
How can I contact diaDexus?
diaDexus' mailing address is 349 Oyster Point Blvd, SOUTH SAN FRANCISCO, CA 94080-1947, United States. The company can be reached via phone at +1-650-2466400.
MarketBeat Community Rating for diaDexus (DDXS)MarketBeat's community ratings are surveys of what our community members think about diaDexus and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
diaDexus (OTCMKTS:DDXS) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
diaDexus (OTCMKTS:DDXS) Earnings History and Estimates Chart
diaDexus (OTCMKTS DDXS) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
diaDexus (OTCMKTS:DDXS) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for diaDexus (OTCMKTS:DDXS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for diaDexus (OTCMKTS DDXS)
No insider trades for this company have been tracked by MarketBeat.com
diaDexus (OTCMKTS DDXS) News Headlines
No headlines for this company have been tracked by MarketBeat.com
diaDexus (OTCMKTS:DDXS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
diaDexus (OTCMKTS DDXS) Stock Chart for Wednesday, January, 17, 2018